Skip to content
★ Sign in to follow
MR

Martin R. Felsenthal

Executive
Teladoc Health, Inc.
Total declarations
4
Company
1
▲ Purchases (3 ops.)
€94k
▼ Sales (0 ops.)
—

Latest filing published 08 Jul 2016 for Teladoc Health, Inc..

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3
Positive at T+90
100%
Median T+90
+14.5%

Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 18 Mar 2016 · 3888 days ago · €92k
    +107.5%
    Entry US$11.23 · Close at T+365 US$23.30

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Martin R. Felsenthal: trading record in brief

Martin R. Felsenthal appears in our data through filings on Teladoc Health, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 17 March 2016 to 7 July 2016.

Every open-market trade on record is a purchase: 3 purchases worth €94k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The median purchase comes to €946. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 3 purchases show a median change of +14.5%, with the price up in 100% of them. They describe history only and say nothing certain about the share price ahead.

On 8 July 2016 came the latest disclosure, a transaction in Teladoc Health, Inc. The latest purchase dates back some time: it was published 3,888 days ago, on 18 March 2016. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Martin R. Felsenthal

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total

4 of 4 declarations